All Bill Titles

• Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
• Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
• Short: Medical Device User Fee Amendments of 2012 as passed senate.
• Short: Generic Drug User Fee Amendments of 2012 as passed senate.
• Short: Biosimilar User Fee Act of 2012 as passed senate.
• Short: Food and Drug Administration Safety and Innovation Act as passed senate.
• Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
• Short: Prescription Drug User Fee Amendments of 2012 as passed house.
• Short: Medical Device User Fee Amendments of 2012 as passed house.
• Short: Generic Drug User Fee Amendments of 2012 as passed house.
• Short: Biosimilar User Fee Act of 2012 as passed house.
• Short: Food and Drug Administration Safety and Innovation Act as passed house.
• Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
• Short: Food and Drug Administration Safety and Innovation Act as introduced.
• Short: Biosimilar User Fee Act of 2012 as introduced.
• Short: Generic Drug User Fee Amendments of 2012 as introduced.
• Short: Medical Device User Fee Amendments of 2012 as introduced.
• Short: Prescription Drug User Fee Amendments of 2012 as introduced.
• Short: Food and Drug Administration Safety and Innovation Act as enacted.
• Short: Biosimilar User Fee Act of 2012 as enacted.
• Short: Generic Drug User Fee Amendments of 2012 as enacted.
• Short: Medical Device User Fee Amendments of 2012 as enacted.
• Short: Prescription Drug User Fee Amendments of 2012 as enacted.
• Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.